Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lorazepam
Drug ID BADD_D01318
Description Lorazepam is a short-acting and rapidly cleared benzodiazepine used commonly as a sedative and anxiolytic.[A957] It was developed by DJ Richards, presented and marketed initially by Wyeth Pharmaceuticals in the USA in 1977. The first historic FDA label approval is reported in 1985 by the company Mutual Pharm.[L5095]
Indications and Usage For the management of anxiety disorders, and for treatment of status epilepticus.
Marketing Status Prescription; Discontinued
ATC Code N05BA06
DrugBank ID DB00186
KEGG ID D00365
MeSH ID D008140
PubChem ID 3958
TTD Drug ID D0E0OG
NDC Product Code 55700-778; 0904-6009; 55289-402; 53002-7721; 52427-663; 0641-6046; 0641-6051; 72572-380; 0409-6778; 60687-638; 68071-5068; 0591-0242; 60687-401; 54348-049; 53002-5291; 69315-905; 76329-8261; 70518-2239; 68788-7480; 52696-0002; 0093-3425; 53002-5290; 61919-607; 13107-085; 0641-6048; 70518-2442; 55289-487; 68071-5137; 51927-1005; 0641-6207; 71610-600; 72166-001; 54348-028; 0641-6003; 71610-122; 67296-1332; 0591-0241; 43063-048; 43063-057; 55154-7976; 0409-6779; 0904-6007; 69315-906; 63629-8185; 0641-6047; 12828-0025; 67296-1629; 71610-178; 55700-745; 70518-1520; 68788-7428; 0641-6049; 65162-017; 70518-0486; 71610-255; 68071-2666; 0641-6001; 50090-0273; 70518-3225; 0409-1985; 76420-296; 45865-499; 67544-142; 0615-8077; 65162-018; 0641-6044; 48087-0076; 65162-015; 50090-0272; 50090-4001; 0409-1539; 68071-5084; 51927-0195; 0409-6780; 71610-199; 52427-667; 0615-8075; 72789-197; 50090-5508; 67296-1622; 60687-355; 67763-101; 50383-705; 68071-5022; 0641-6000; 49452-4140; 71205-228; 58118-1095; 63187-536; 68788-7533; 71335-0655; 13107-084; 13107-083; 70518-3188; 71205-166; 61919-062; 63629-2953; 68071-5061; 68071-5048; 71335-0329; 58118-1096; 70518-0445; 0591-0240; 0641-6045; 71610-229; 0641-6050; 62991-1682; 69315-904; 71335-1694; 68071-4882; 0054-3532; 63187-576; 71554-009; 53002-6290; 50090-4191; 68071-3096; 58118-0904; 60760-516; 50090-4157; 50090-5509; 60687-627; 71335-1467; 0187-0065; 72789-236; 17856-2059; 52427-661; 72789-226; 0093-3426; 50090-5081; 43353-255; 68071-4918; 71610-008; 0641-6002; 68071-3242; 71335-1138; 70518-2268; 68071-3227; 0093-3427; 68788-7355; 68071-2662; 63275-9979; 0121-0770; 0615-8076; 67544-191; 38779-0927; 0395-8161; 68071-4916; 70518-2186; 71610-225; 55154-7975; 70518-0275; 52427-658; 68071-5250; 50090-2810; 17478-040; 60687-649; 65162-687; 0187-0063; 51552-0729; 64330-020; 71205-235; 68071-3121; 67296-0143; 50090-3462; 67544-261; 17856-3532; 0904-6008; 57218-950; 0187-0064
Synonyms Lorazepam | Ativan | Orfidal Wyeth | Wyeth, Orfidal | Témesta | Tolid | Donix | Duralozam | Durazolam | Idalprem | Laubeel | Lorazep Von Ct | Von Ct, Lorazep | Lorazepam Medical | Medical, Lorazepam | Lorazepam-Neuraxpharm | Lorazepam Neuraxpharm | Lorazepam-Ratiopharm | Lorazepam Ratiopharm | Novo-Lorazem | Novo Lorazem | Nu-Loraz | Nu Loraz | Sedicepan | Sinestron | WY-4036 | WY 4036 | WY4036 | Apo-Lorazepam | Apo Lorazepam | Somagerol | Temesta
Chemical Information
Molecular Formula C15H10Cl2N2O2
CAS Registry Number 846-49-1
SMILES C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Flatulence07.01.04.002--
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Foreign body aspiration22.02.07.008; 12.01.03.0010.000134%Not Available
Gait disturbance17.02.05.016; 08.01.02.0020.001611%
Gangrene24.04.05.003; 23.06.06.001; 11.02.01.003--Not Available
Gastrooesophageal reflux disease07.02.02.003--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Generalised tonic-clonic seizure17.12.01.0020.000201%Not Available
Gynaecomastia21.05.04.003; 05.05.02.0030.000134%
Haematemesis24.07.02.011; 07.12.02.002--Not Available
Haematoma24.07.01.001--
Haemoglobin decreased13.01.05.003--Not Available
Hallucination19.10.02.0020.001812%
Hallucination, auditory19.10.02.0030.000134%Not Available
Hallucination, visual19.10.02.0040.000201%Not Available
Headache17.14.01.001--
Heart rate decreased13.14.04.0010.000268%Not Available
Heart rate increased13.14.04.0020.000336%Not Available
Hepatic cirrhosis09.01.04.0010.000035%Not Available
Hepatic encephalopathy09.01.03.006; 17.13.01.0030.000201%Not Available
Hepatitis09.01.07.0040.000201%Not Available
Hepatitis acute09.01.07.0050.000134%Not Available
Hepatocellular injury09.01.07.008--Not Available
Hip fracture15.08.03.001; 12.04.01.0010.000053%
Hostility19.05.01.003--Not Available
Hypercalcaemia14.04.01.003; 05.04.01.0020.000134%
Hypercapnia22.02.02.002; 14.01.04.0010.000738%Not Available
Hyperhidrosis23.02.03.004; 08.01.03.0280.001342%
Hyperkalaemia14.05.03.0010.000336%
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 16 Pages